Targeting N-acetyltransferase 10 reprograms Treg function to enhance anti–PD-1 immunotherapy sensitivity in murine lung tumors
Journal of Clinical Investigation · 02.11.2026 · 136 (21)
DOI: 10.1172/jci189034 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 02.11.2026. Verfasst von Xuewei Qi und 22 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Immune Response and Immunotherapy, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Sc…. Hauptthemen laut MEDLINE: T-Lymphocytes, Regulatory, Lung Neoplasms, Programmed Cell Death 1 Receptor, Immunotherapy. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
A significant challenge for improving the efficacy of immune checkpoint blockade (ICB) therapy is the concurrent activation of Tregs, which can dampen antitumor responses. Thus, elucidating the mechanisms that maintain Treg-suppressive function within the tumor microenvironment is critical. Here, we identified an accumulation of N-acetyltransferase 10–modified (NAT10-modified) RNA, particularly in NAT10 + FOXP3 + Tregs, in human non–small cell lung cancer. Genetic ablation of Nat10 in tumor-infiltrating (TI) Tregs, or pharmacological inhibition of NAT10 expression, significantly reduced the PD-1 + Treg/CD8 + T cell ratio. These effects were accompanied by an increase in IFN-γ + Tregs, a reduction in the immunosuppressive activity of Tregs, and inhibition of tumor progression. Mechanistically, NAT10 promotes TI Treg infiltration and activation independently of its RNA-modifying function by directly interacting with FOXP3 and chromatin, modulating local 3D chromatin contacts. Combined administration of anti–PD-1 antibodies and a NAT10 inhibitor further impaired TI Treg–mediated immunosuppression, leading to enhanced tumor control. Our findings demonstrate that NAT10 is a key regulator of TI Treg fragility and function and that its inhibition may enhance the therapeutic efficacy of ICB.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Immune Response and Immunotherapy, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
- Guangzhou National Laboratory, Xing Dao Huan Bei Road, Guangzhou International Bio Island, Guangzhou, China.
- Ministry of Education Key Laboratory for Cellular Dynamics, Center for Advanced Interdisciplinary Science and Biomedicine of Institute of Health and Medicine (IHM), Division of Life Sciences and Medicine, University of…
- Department of Chest Surgery, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, China.
- Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen Universi…
- Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, China.
Zitieren
APA
Qi, X., Cui, D., Li, X., Fu, W., Ma, H., Guo, W., Wang, J., Song, J., Ma, J., Yang, J., Yu, H., Hong, Y., Wang, Q., Luo, S., Wang, J., Wu, B., Li, S., Cheng, H., Cheng, M., …, & Li, F. (2026). Targeting N-acetyltransferase 10 reprograms Treg function to enhance anti–PD-1 immunotherapy sensitivity in murine lung tumors. Journal of Clinical Investigation, 136(21). https://doi.org/10.1172/jci189034
Vancouver
Qi X, Cui D, Li X, Fu W, Ma H, Guo W, et al. Targeting N-acetyltransferase 10 reprograms Treg function to enhance anti–PD-1 immunotherapy sensitivity in murine lung tumors. Journal of Clinical Investigation. 2026;136(21). doi:10.1172/jci189034
BibTeX
@article{Qi2026,
author = {Qi, Xuewei and Cui, Dan and Li, Xiao and Fu, Wenfan and Ma, Handong and Guo, Wenting and Wang, Jiabao and Song, Jiaxi and Ma, Jiaxin and Yang, Jing and Yu, Haoyu and Hong, Yuting and Wang, Qian and Luo, Susu and Wang, Jia and Wu, Baixing and Li, Shanshan and Cheng, Hao and Cheng, Min and Li, Bin and Zhang, Kaiming and Li, Jia and Li, Fengyin},
title = {Targeting N-acetyltransferase 10 reprograms Treg function to enhance anti–PD-1 immunotherapy sensitivity in murine lung tumors},
journal = {Journal of Clinical Investigation},
year = {2026},
volume = {136},
number = {21},
doi = {10.1172/jci189034}
}
EUVIMED